MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) Meeting Abstract
| Authors: | Strickler, J. H.; Ng, K.; Cercek, A.; Fountzilas, C.; Sanchez, F. A.; Hubbard, J. M.; Wu, C.; Siena, S.; Tabernero, J.; Van Cutsem, E.; Kardosh, A.; Saeed, A.; Andre, T.; Stecher, M.; Palanca-Wessels, M. C.; Bekaii-Saab, T. S. |
| Abstract Title: | MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800013 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS153 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS153 -- Source: Wos |
